Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.82, $0.36 better than the analyst estimate of $0.46. Revenue for the quarter came in at $274.3 million versus the consensus estimate of $263.97 million.

GUIDANCE:

Dolby Laboratories sees Q3 2016 EPS of $0.62-$0.68, versus the consensus of $0.40. Dolby Laboratories sees Q3 2016 revenue of $260-275 million, versus the consensus of $253.70 million.

Dolby Laboratories sees FY2016 revenue of $1.0-1.03 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.